Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects

Mise à jour : Il y a 5 ans
Référence : NCT01208285

Femme et Homme

Extrait

The purpose of this study is to investigate the pharmacokinetics and safety of a single dose of VX-770 in subjects with moderate hepatic impairment.


Critère d'inclusion

  • In Development for Cystic Fibrosis

Liens